S. Johnson

发表

BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line

D. Bigner, H. Friedman, M. Bacolod, 2009, Cancer Chemotherapy and Pharmacology.

O4-benzylfolic acid inactivates O6-alkylguanine-DNA alkyltransferase in brain tumor cell lines

D. Bigner, H. Friedman, B. Kamen, 2007, Cancer Chemotherapy and Pharmacology.

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma

R. McLendon, A. Friedman, D. Bigner, 2006, Molecular Cancer Therapeutics.

Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells

D. Bigner, H. Friedman, F. Ali-Osman, 2010, Journal of biomedical research.

Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcoma.

D. Bigner, H. Friedman, F. Ali-Osman, 2002, Molecular cancer therapeutics.

Modulation of cyclophosphamide activity by O 6-alkylguanine-DNA alkyltransferase

M. Dolan, S. Keir, D. Bigner, 1999, Cancer Chemotherapy and Pharmacology.

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts

S. Keir, D. Bigner, P. Houghton, 2000, Cancer Chemotherapy and Pharmacology.

Termination of transcription of ribosomal RNA in Saccharomyces cerevisiae

J. Warner, S. Johnson, J. R. Warner, 2004, Molecular and Cellular Biochemistry.

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft

S. Keir, D. Bigner, H. Friedman, 2005, Molecular Cancer Therapeutics.

A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells

D. Bigner, H. Friedman, M. Bektas, 2009, Cancer Chemotherapy and Pharmacology.

Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.

M. Dolan, D. Bigner, H. Friedman, 2004, Molecular cancer therapeutics.

Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma

R. McLendon, A. Friedman, D. Bigner, 2008, Clinical Cancer Research.

Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)

D. Bigner, R. Nahta, H. Friedman, 1999, Cancer Chemotherapy and Pharmacology.

Chapter 22 Early Gene Expression in the Activation of Mononuclear Phagocytes

D. Adams, S. Johnson, R. J. Uhing, 1990 .

Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.

H. Friedman, O. Colvin, S. Johnson, 2002, Cancer treatment and research.

Thoughts on the Phosphorylation of a Ribosomal Protein

C. McLaughlin, S. Johnson, J. R. Warner, 1988 .